Cardiovascular Systems (CSII) Guides Low 2Q16 Given Lingering Headwinds; Needham & Company Reiterates Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Cardiovascular Systems Reports Fiscal 2016 First-Quarter Financial Results
November 4, 2015 4:06 PM ESTConference Call Scheduled for Today, November 4, 2015, at 3:45 PM CT (4:45 PM ET)
Revenues of $43.9 million and net loss of $(0.41) per share were in line with preliminary results guidance range Company enrolls first patients in OPTIMIZE study LIBERTY 360° study update provided at VIVA Conference; enrollment exceeds 1,100, including over 600 patients with Rutherford classification stages of 4, 5 and 6 TRUTH study demonstrates that CSIs Orbital Atherectomy System is effective at reducing and modifying calciumST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular... More
